User contributions
(newest | oldest) View (newer 50 | older 50) (20 | 50 | 100 | 250 | 500)
- 12:28, 23 January 2021 (diff | hist) . . (+1,583) . . N Flumatinib (HH-GV-678) (Created page with "==General information== From the [https://www.cancer.gov/publications/dictionaries/cancer-drug/def/flumatinib-mesylate NCI Drug Dictionary]: The orally bioavailable, mesylate...") (current)
- 12:26, 23 January 2021 (diff | hist) . . (+53) . . m Drug index (→F) (current)
- 12:24, 23 January 2021 (diff | hist) . . (+913) . . m Chronic myelogenous leukemia (→Imatinib monotherapy {{#subobject:917a16|Regimen=1}}) (current)
- 12:08, 23 January 2021 (diff | hist) . . (+900) . . m Acute myeloid leukemia - null regimens (→Observation) (current)
- 12:06, 23 January 2021 (diff | hist) . . (+59) . . m Acute myeloid leukemia (→Azacitidine Oral monotherapy {{#subobject:da9efa|Regimen=1}}) (current)
- 10:51, 23 January 2021 (diff | hist) . . (+1,695) . . m Non-small cell lung cancer (→Cisplatin & Paclitaxel {{#subobject:7f19fc|Regimen=1}}) (current)
- 08:37, 23 January 2021 (diff | hist) . . (+3,318) . . m Colon cancer (→mFOLFOX6 (L-Leucovorin) {{#subobject:32d6c5|Regimen=1}}) (current)
- 17:28, 22 January 2021 (diff | hist) . . (-30) . . m Category:Anti-VEGFR antibodies (current)
- 17:28, 22 January 2021 (diff | hist) . . (+9) . . m Category:VEGFR inhibitors (current)
- 17:27, 22 January 2021 (diff | hist) . . (+9) . . m Category:TXK inhibitors (current)
- 17:26, 22 January 2021 (diff | hist) . . (+8) . . m Category:TRK inhibitors (current)
- 17:25, 22 January 2021 (diff | hist) . . (+9) . . m Category:TEK inhibitors (current)
- 17:25, 22 January 2021 (diff | hist) . . (+9) . . m Category:TEC inhibitors (current)
- 17:22, 22 January 2021 (diff | hist) . . (+9) . . m Category:PTK2 inhibitors (current)
- 17:22, 22 January 2021 (diff | hist) . . (+17) . . m Category:PLK1 inhibitors (current)
- 17:16, 22 January 2021 (diff | hist) . . (+9) . . m Category:PDGFR inhibitors (current)
- 17:15, 22 January 2021 (diff | hist) . . (+17) . . m Category:MTOR inhibitors (current)
- 17:15, 22 January 2021 (diff | hist) . . (+47) . . m Category:MET inhibitors (current)
- 17:14, 22 January 2021 (diff | hist) . . (+9) . . m Category:ROS1 inhibitors (current)
- 17:14, 22 January 2021 (diff | hist) . . (+9) . . m Category:SYK inhibitors (current)
- 17:13, 22 January 2021 (diff | hist) . . (+9) . . m Category:SRC inhibitors (current)
- 17:12, 22 January 2021 (diff | hist) . . (-20) . . m Category:MAP4K5 inhibitors (current)
- 17:12, 22 January 2021 (diff | hist) . . (+17) . . m Category:MEK inhibitors (current)
- 17:12, 22 January 2021 (diff | hist) . . (+17) . . m Category:MAP4K5 inhibitors
- 17:12, 22 January 2021 (diff | hist) . . (+17) . . m Category:MAP3K20 inhibitors (current)
- 17:11, 22 January 2021 (diff | hist) . . (+9) . . m Category:JAK inhibitors (current)
- 17:10, 22 January 2021 (diff | hist) . . (+9) . . m Category:IGFR inhibitors (current)
- 17:09, 22 January 2021 (diff | hist) . . (+9) . . m Category:FGFR inhibitors (current)
- 17:09, 22 January 2021 (diff | hist) . . (+9) . . m Category:DDR inhibitors (current)
- 17:07, 22 January 2021 (diff | hist) . . (+9) . . m Category:CSF1R inhibitors (current)
- 17:06, 22 January 2021 (diff | hist) . . (+17) . . m Category:CK1 inhibitors (current)
- 17:05, 22 January 2021 (diff | hist) . . (+17) . . m Category:CDK inhibitors (current)
- 17:03, 22 January 2021 (diff | hist) . . (+17) . . m Category:BRAF inhibitors (current)
- 16:59, 22 January 2021 (diff | hist) . . (+156) . . m Category:RAF1 inhibitors (current)
- 16:58, 22 January 2021 (diff | hist) . . (+9) . . m Category:RET inhibitors (current)
- 16:58, 22 January 2021 (diff | hist) . . (+128) . . m Category:ITK inhibitors (current)
- 16:57, 22 January 2021 (diff | hist) . . (+52) . . m Category:KIT inhibitors (current)
- 16:55, 22 January 2021 (diff | hist) . . (+9) . . m Category:FLT3 inhibitors (current)
- 16:55, 22 January 2021 (diff | hist) . . (+9) . . m Category:BTK inhibitors (current)
- 16:55, 22 January 2021 (diff | hist) . . (+9) . . m Category:Bcr-Abl inhibitors (current)
- 14:04, 22 January 2021 (diff | hist) . . (+532) . . m Renal cell carcinoma (→Cabozantinib & Nivolumab {{#subobject:e3igp6|Regimen=1}}) (current)
- 14:02, 22 January 2021 (diff | hist) . . (+1,208) . . Renal cell carcinoma (→Cabozantinib monotherapy {{#subobject:e3ff16|Regimen=1}})
- 13:58, 22 January 2021 (diff | hist) . . (+185) . . m Nivolumab (Opdivo) (→Renal cell carcinoma) (current)
- 09:32, 22 January 2021 (diff | hist) . . (+161) . . m Category:AXL inhibitors (current)
- 08:57, 22 January 2021 (diff | hist) . . (+17) . . m Category:Aurora kinase inhibitors (current)
- 08:57, 22 January 2021 (diff | hist) . . (+68) . . m Category:ALK inhibitors (current)
- 08:55, 22 January 2021 (diff | hist) . . (+30) . . N Category:Serine/threonine kinase inhibitors (Created page with "Category:Kinase inhibitors") (current)
- 08:55, 22 January 2021 (diff | hist) . . (+45) . . m Category:AKT1 inhibitors (current)
- 08:53, 22 January 2021 (diff | hist) . . (+164) . . m Category:ERBB4 inhibitors (current)
- 08:52, 22 January 2021 (diff | hist) . . (+193) . . m Category:ERBB3 inhibitors (current)
(newest | oldest) View (newer 50 | older 50) (20 | 50 | 100 | 250 | 500)
